MaxCyte, Inc. (MXCT.L)

GBp 346.0

(0.87%)

Revenue Summary of MaxCyte, Inc.

  • MaxCyte, Inc.'s latest annual revenue in 2023 was 41.28 Million USD , down -6.72% from previous year.
  • MaxCyte, Inc.'s latest quarterly revenue in 2024 Q2 was 10.42 Million USD , down -8.05% from previous quarter.
  • MaxCyte, Inc. reported a annual revenue of 44.26 Million USD in annual revenue 2022, up 30.59% from previous year.
  • MaxCyte, Inc. reported a annual revenue of 33.89 Million USD in annual revenue 2021, up 29.52% from previous year.
  • MaxCyte, Inc. reported a quarterly revenue of 10.42 Million USD for 2024 Q2, down -8.05% from previous quarter.
  • MaxCyte, Inc. reported a quarterly revenue of 8.57 Million USD for 2023 Q1, down -30.97% from previous quarter.

Annual Revenue Chart of MaxCyte, Inc. (2023 - 2012)

Historical Annual Revenue of MaxCyte, Inc. (2023 - 2012)

Year Revenue Revenue Growth
2023 41.28 Million USD -6.72%
2022 44.26 Million USD 30.59%
2021 33.89 Million USD 29.52%
2020 26.16 Million USD 21.04%
2019 21.62 Million USD 29.72%
2018 16.66 Million USD 19.18%
2017 13.98 Million USD 13.98%
2016 12.26 Million USD 32.07%
2015 9.29 Million USD 29.67%
2014 7.16 Million USD 5.28%
2013 6.8 Million USD 34.5%
2012 5.05 Million USD 0.0%

Peer Revenue Comparison of MaxCyte, Inc.

Name Revenue Revenue Difference